Insulin resistance (metabolic) syndrome in children

Panminerva Medica

Volumn 47, Issue 4, 2005, Pages 229-244

  Rosenberg, B ^a   Moran, A ^a   Sinaiko, A R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular diseases; Child; Insuline resistence

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; BLOOD; CHILD; ETHNOLOGY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; METABOLIC SYNDROME X; METABOLISM; OBESITY; OXIDATIVE STRESS; REVIEW; RISK FACTOR;

ADOLESCENT; C-REACTIVE PROTEIN; CHILD; HUMANS; HYPERTENSION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; LIPOPROTEINS, VLDL; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 33645289952     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (158)

1. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
2. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
3. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 2004;33:283-303.
4. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
5. Ford E, Giles W, Dietz WH. Prevalence of the metabolic syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
6. Clarke WR, Lauer RM. Does childhood obesity track into adulthood? Crit Rev Food Sci Nutr 1993;33:423-30.
7. DiPietro L, Mossberg HO, Stunkard AJ. A 40-year history of overweight children in Stockholm: Life-time overweight, morbidity, and mortality. Int J Obesity 1994;18:585-90.
8. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. N Engl J Med 1992;327:1350-5.
9. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa Heart Study. Am J Hypertens 1995;8:657-65.
10. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: The Bogalusa Heart Study. Am J Epidemiol 1991;133:884-99.
11. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998;338:1650-6.
12. Natali A, Ferrannini E. Hypertension, insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin N Am 2004;33:417-29.
13. National Institutes of Health. Third Report of the National Cholesterol Education Program; 2001.
14. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings From the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7.
15. Ford E, Giles W. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26:575-81.
16. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004;145:445-51.
17. Rodriguez-Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care 2004;27:2516-7.
18. Lambert M, Paradis G, Delvin E, Hanley J, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes 2004;28:833-41.
19. Viner R, Segal T, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005;90:10-4.
20. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
21. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin N Am 2004;88:787-835.
22. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004;89:463-78.
23. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992;15:318-68.
24. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S et al. Clinical course of genetic diseases of the insulin receptor (Type A and Rabson-Mendenhall Syndromes): a 30-year prospective. Medicine 2004;83:209-22.
25. Trischitta V, Frittitta L, Vigneri R. Early molecular defects in human insulin resistance: studies in healthy subjects with low insulin sensitivity. Diabetes Metab Rev 1997;13:147-62.
26. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 2000;106:329-33.
27. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986;315:215-9.
28. Bloch C, Clemons P, Sperling M. Puberty decreases insulin sensistivity. J Pediatr 1987;110:481-7.
29. Caprio S, Plewe G, Diamond M, Simonson DC, Boulware SD, Sherwin RS et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989;114:963-7.
30. Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-44.
31. Moran A, Jacobs DR, Steinberger J, Cohen P, Hong C-P, Prineas R et al. Association between the insulin resistance of puberty and the insulin-like growth factor-i/growth hormone axis. J Clin Endocrinol Metab 2002;87:4817-20.
32. Caprio S, Cline G, Boulware S, Permanente C, Shulman GI, Sherwin RS et al. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. Endocrinol Metab 1994;29:E885-91.
33. Johnson M, Figueroa-Colon R, Huang TT-K, Dwyer J, Goran MI. Longitudinal changes in body fat in African American and Caucasian children: influence of fasting insulin and insulin sensitivity. J Clin Endocrinol Metab 2001;86:3182-7.
34. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996;39:1489-97.
35. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362:951-7.
36. Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2002;15:487-92.
37. Sinaiko AR, Jacobs DR, Steinberger J, Moran A, Luepker R, Rocchini AP et al. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001;139:700-7.
38. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-6.
39. Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 2002;25:2184-90.
40. Jaing X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Racial (Black-White) differences in insulin secretion and clearance in adolescents: The Bogalusa Heart Study. Pediatrics 1996;97:357-60.
41. Arslanian S, Suprasongsin C, Janosky JE. Insulin secretion and sensitivity in black versus white prepubertal healthy children. J Clin Endocrinol Metab 1997;82:1923-7.
42. Svec F, Natstasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS. Black-White contrasts in insulin levels during pubertal development: The Bogalusa Heart Study. Diabetes 1992;41:313-7.
43. Arslanian S, Suprasongsin C. Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents. J Pediatr 1996;129:440-3.
44. Steffen Batey L, Goff DC, Tortolero SR, Nichaman MZ, Chan W, Chan FA et al. Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic White children: The Corpus Christi Child Heart Study. Circulation 1997;96:4319-25.
45. Gower BA, Nagy TR, Trowbridge CA, Dezenberg C, Goran MI. Fat distribution and insulin response in prepubertal African American and white children. Am J Clin Nutr 1998;67:821-7.
46. Uwaifo GI, Nguyen TT, Keil MF, Russell DL, Nicholson JC, Bonat SH et al. Differences in insulin secretion and sensitivity of Caucasian and African American prepubertal children. J Pediatr 2002;140:673-80.
47. Arslanian S, Saad R, Vered L, Danadian K, Janosky JE. Hyperinsulinemia in African-American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002;51:3014-9.
48. Crawford PB, Story M, Wang MC, Ritchie LD, Sabry ZI. Ethnic issues in the epidemiology of childood obesity. Pediatr Clin N Am 2001;48:855-78.
49. Flegal KM, Carroll MD, Ogden CI, Johnson CL. Prevalence and trends in obesity among U.S. adults, 1999-2000. JAMA 2002;288:1723-7.
50. Sokol R. The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr 2000;136:711-3.
51. Ogden C, Flegal K, Carroll M, Johnson C. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-32.
52. Sinaiko AR, Donahue RP, Jacobs DR, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. Circulation 1999;99:1471-6.
53. Steinberger J, Moran A, Hong CP, Jacobs DR, Sinaiko AR. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 2001;138:469-73.
54. Sinha R, Fisch G, Teague BR, Tamborlane WV, Banyas B, Allen K et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
55. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005;28:902-9.
56. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000;49:883-8.
57. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000;11:351-6.
58. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E et al. Visceral fat in hypertension: influence on inulin resistance and beta-cell function. Hypertension 2004;44:127-33.
59. Bolinder J, Karger L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983;32:117-27.
60. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-29.
61. Chu N-F, Chang J-B, Shieh S-M. Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children. Obes Res 2003;11:532-40.
62. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997;46:3-10.
63. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001;50:1612-7.
64. Boden G, Shulman G. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002;32 Suppl 3:14-23.
65. Caprio S, Hyman LD, Limb C, McCarthy S, Lange R, Sherwin RS et al. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995;269(1 Pt 1):E118-26.
66. Owens S, Gutin B, Ferguson M, Allison J, Karp W, Ngoc-Anh L. Visceral adipose tissue and cardiovascular risk factors in obese children. J Pediatr 1998;133:41-5.
67. Gower BA, Nagy TR, Goran MI. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 1999;48:1515-21.
68. Berberoglu M. Evaluation of the correlation between serum tumor necrosis factor-( and relative body mass index (RBMI) in childhood. J Pediatr Endocrinol Metab 2001;14:543-7.
69. Moon YS, Kim DH, Song DK. Serum tumor necrosis factor-( levels and components of the metabolic syndrome in obese adolescents. Metabolism 2004;53:863-7.
70. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005;111:1985-91.
71. Asayama K, Hayashibe H, Dobashi K, Uchida N, Nakane T, Kodera K et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation. Obes Res 2003;11:1072-9.
72. Reinehr T, Roth C, Menke T, Andler W. Adiponectin before and after weight loss in obese children. J Clin Endocrinol Metab 2004;89:3790-4.
73. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth. Diabetes Care 2004;27:547-51.
74. Tsou PL, Jiang YD, Chang CC, Wei JN, Sung FC, Lin CC et al. Sex-related differences between adiponectin and insulin resistance in school children. Diabetes Care 2004;27:308-13.
75. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997;82:2904-10.
76. Arslanian S, Suprasongsin C, Kalhan SC, Drash AL, Brna R, Janosky JE. Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity and energy expenditure. Metabolism 1998;47:309-12.
77. Steinberger J, Steffen L, Jacobs DR, Moran A, Hong C-P, Sinaiko AR. Relation of leptin to insulin resistance syndrome in children. Obes Res 2003;11:1124-30.
78. Rudich A, Tirosh A, Potahnik R, Hami R, Kanety H, Bashau N. Prolonged oxidative stress impairs insulin-induced GLUT 4 trans location in 3T3-LI adipocytes. Diabetes 1998;47:1562-9.
79. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 2000;77:526-30.
80. Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E et al. Oxidative stress in juvenile essential hypertension. J Hypertens 2003;21:145-52.
81. Yeh ETH, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 2003;107:370-1.
82. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002;106:2908-12.
83. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E. C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 2004;50:1762-8.
84. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005;28:878-81.
85. Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Nat Med Ass 2003;95:545-52.
86. Vikram N, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003;168:305-13.
87. Shea S, Aymong E, Zybert P, Shamoon H, Tracy RP, Deckelbaum RJ et al. Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res 2003;11:95-103.
88. Wu DM, Chu NF, Shen MH, Chiang JB. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2004;56:94-100.
89. Cook D, Mendall M, Whincup P, Carey IM, Ballam L, Morris JE et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149:139-50.
90. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circ 2003;108:1053-8.
91. Moran A, Steffen LM, Jacobs DR, Steinberger J, Pankow JS, Hong CP et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 2005;28:1763-8.
92. Sorof JM, Daniels SR. Obesity hypertension in children: a problem of epidemic proportions. Hypertension 2002;40:441-7.
93. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990;39:167-74.
94. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. Hypertension 1997;30:1144-9.
95. Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension 1992;19:I61-6.
96. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
97. DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976;58:83-90.
98. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975;36:319-27.
99. Adeyanju M, Creswell WH, Stone DB, Macrina DM. A three-year study of obesity and its relationship to high blood pressure in adolescents. J Sch Health 1987;57:109-13.
100. Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with blood pressure in young individuals. The Bogalusa Heart Study. Arch Intern Med 1993;153:323-8.
101. Sinaiko AR, Gomez-Marin O, Prineas RJ. Relation of fasting insulin to blood pressure and lipids in adolescents and parents. Hypertension 1997;30:1554-9.
102. Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Åkerblom HK. Insulin and blood pressure among healthy children: cardiovascular risk in young Finns. Am J Hypertens 1996;9:193-9.
103. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Jacobs DR. Relation of insulin resistance to blood pressure in childhood. J Hypertens 2002;20:509-17.
104. Lewis GF, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996;12:37-56.
105. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995;95:158-66.
106. Malmstrom R, Packard C, Caslake M, Bedford D, Stewart P, Yki-Jarvinen H et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 1997;40:454-62.
107. Assimacopoulos-Jeannet F, Brichard S, Rencurel F, Cusin I, Jeanrenaud B. In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter experssion in rat liver and adipose tissues. Metabolism 1995;44:228-33.
108. Golay A, Shi M-Z, Chiou Y-AM, Reaven GM, Chen Y-DI. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metab 1987;65:512-8.
109. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000;159:91-4.
110. Jaing X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: The Bogalusa Heart Study. Arch Intern Med 1995;155:190-6.
111. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 1999;103:1175-82.
112. Steinberger J, Moorehead C, Katch V, Rocchini A. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995;126:690-5.
113. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is "Syndrome X" present? J Clin Endocrinol Metab 1996;81:1058-62.
114. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) polulation of children, adolescents, and young adults. Am J Epidemiol 1999;150:667-74.
115. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR. Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of Black and White subjects: The Bogalusa Heart Study. Diabetes 2000;49:1042-8.
116. Sinaiko AR, Jacobs DR, Steinberger J, Moran A, Luepker R, Rocchini AP et al. Insulin resistance syndrome in children: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr 2001;139:700-7.
117. Bergstrom E, Hernell O, Persson L, Vessby B. Insulin resistance syndrome in adolescents. Metabolism 1996;45:908-14.
118. Meigs J, D'Agostino Sr R, Wilson P. Risk variable clustering in the insulin resistance syndrome: The Framingham Offspring Study. Diabetes 1997;46:1594-60.
119. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Intern Med 1994;154:1842-7.
120. Karelis AD, Brochu M, Rabasa-Lhoret R, Garrel D, Poehlman ET. Clinical markers for the identification of metabolically healthy but obese individuals. Diab Obes Metab 2004;6:456-7.
121. Sinaiko AR, Jacobs DR, Steinberger J, Moran A. Influence of insulin resistance in childhood on systolic blood pressure and insulin resistance syndrome in early young adulthood. Hypertension 2004;44:503.
122. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991;91:589-96.
123. Beatty O, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. BMJ 1993;307:92-6.
124. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. The relation of parental cardiovascular disease to risk factors in children and young adults: The Bogalusa Heart Study. Circulation 1995;91:365-71.
125. Haffner S, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E. Parental history of diabetes is associated with increased cardiovascular risk factors. Ateriosclerosis 1989;9:928-33.
126. Pankow JS, Jacobs DR, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care 2004;27:775-80.
127. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiologic evidence. J Pediatr Endocrinol Metab 2000;13:1395-402.
128. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury P, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128:608-15.
129. Molnar D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes 2004;28 Suppl 3:S70-S4.
130. Livingstone M. Childhood obesity in Europe: a growing concern. Pub Health Nutr 2001;4(1A):109-16.
131. Fagot-Campagna A, Pettitt D, Engelgau M, Burrows NR, Geiss LS, Valdez R et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136:664-72.
132. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler PS. The Type 2 Family. Arch Pediatr Adolesc Med 1999;153:1063-7.
133. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999;22:345-54.
134. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A et al. Clinical and genetic characteristics of Type 2 diabetes with and without gad antibodies. Diabetes 1999;48:150-7.
135. Zinman B, Kahn S, Haffner S, O'Neill MC, Heise MA, Freed MI. ADOPT Study Group. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 2004;53:3193-200.
136. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 2003;26:2871-5.
137. Arslanian S, Danadian K. Insulin secretion, insulin sensitivity and diabetes in Black children. Trends Endocrinol Metab 1998;9:194-9.
138. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 2004;89:2526-39.
139. Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE. Elevated free IGF-1 levels in prepubertal hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J Clin Endocrinol Metab 2002;87:398-403.
140. Pintor C, Loche S, Faedda A, Fanni V, Nurchi A, Corda R. Adrenal androgens in obese boys before and after weight loss. Hormone Metab Res 1984;16:544-8.
141. Ibanez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-8.
142. Kristiansen S, Endoh A, Casson PR, Buster J, Hornsby P. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids 1997;62:258-65.
143. Ledger W. What to do about the polycystic ovary 'epidemic'. Curr Opin Obstet Gynecol 2002;14:293-4.
144. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Ermans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1017-23.
145. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-9.
146. Lewy VD, Danadian K, Witchel SF, Arslanian S. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 2001;138:38-44.
147. Sondike SB, Copperman N, Jacobson MS. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003;142:253-8.
148. Spieth LE, Harnish JD, Lenders CM, Raezer LB, Pereira MA, Hangen SJ et al. A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 2000;154:947-51.
149. Steffen LM, Jacobs DR, Murtaugh M, Moran A, Steinberger J, Hong CP et al. Whole grain intake is associated with lower body mass and greater insulin sensitivity among adolescents. Am J Edpidemiol 2003;158:243-50.
150. Nielsen SJ, Popkin BM. Changes in beverage intake between 1977 and 2001. Am J Prev Med 2004;27:205-10.
151. Schmitz KH, Jacobs DR, Hong C-P, Steinberger J, Moran A, Sinaiko AR. Association of physical activity with insulin sensitivity in children. Int J Obes 2002;26:1310-6.
152. Saito I, Nishino M, Kawabe H, Wainai H, Hasegawa C, Saruta T et al. Leisure time physical activity and insulin resistance in young obese students with hypertension. Am J Hypertens 1992;5:915-8.
153. Dennison BA, Erb TA, Jenkins PL. Television viewing and television in bedroom associated with overweight risk among low-income pre-school children. Pediatrics 2002;109:1028-35.
154. Crespo CJ, Smit E, Troiano RP, Bartlett SJ, Macera CA, Andersen RE. Television watching, energy intake, and obesity in US children: results From the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2001;155:360-5.
155. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 2003;26:557-62.
156. Balagopal P, George D, Patton N, Yarandi H, Roberts WL, Bayne E et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005;146:342-8.
157. Isasi CR, Deckelbaum RJ, Tracy RP, Starc TJ, Berglund L, Shea S. Physical fitness and C-reactive protein level in children and young adults: The Columbia University BioMarkers Study. Pediatrics 2003;111:332-8.
158. Isasi CR, Starc TJ, Tracy RP, Deckelbaum R, Berglund L, Shea S. Inverse association of physical fitness with plasma fibrinogen level in children: The Columbia University BioMarkers Study. Am J Epidemiol 2000;152:212-8.